Month:September 2016
Mylan Medicaid Fraud Investigations
Kaitlin Lavin Executive Editor Loyola University Chicago School of Law, JD 2017 Mylan has already been under public scrutiny for increasing the price of its EpiPen allergy shots. Last week the State of West Virginia launched a Medicaid fraud investigation questioning Mylan’s price hike and compliance with drug rebate laws. Mylan Pharmaceuticals participates in …
Read more
CMS Issues Proposed Rule Addressing Multiple Fraud and Abuse Concerns
Kaitlin Lavin Executive Editor Loyola University Chicago School of Law, JD 2017 The Centers for Medicare and Medicaid Services (CMS) recently proposed a new rule in the Federal Register that addresses changes in Medicare payment policies. The proposed rule aims to inform providers of proper billing practices and prevent fraud and abuse. This post …
Read more
Medicare Advantage Audits Reveal Alleged Rampant Upcoding
Kaitlin Lavin Executive Editor Loyola University Chicago School of Law, JD 2017 Last month, the Center for Public Integrity obtained over three-dozen new Medicare Advantage (MA) audits through a lawsuit brought under the Freedom of Information Act. The audits indicate that overcharging is still a pervasive problem in the MA Program because Medicare Advantage …
Read more
Medicare Regulations Compliance for Long-term Care Hospitals-within-Hospitals
Christine S. Kim Assistant Editor Loyola University Chicago School of Law, J.D. 2017 Due to the inextricably association between long-term care Hospitals-within-Hospitals (“HwHs”) and their respective Long Term Care Hospitals (“LTCH”), or host hospitals, efforts to circumvent compliance with federal reimbursement regulations have evolved. This blog article discusses the ways in which the Centers …
Read more
Compliance and The Dab
Ryan Whitney Managing Editor Loyola University School of Law, JD 2017 Dabbing has taken pop culture by storm in just the last year. Popularized by Carolina Panther’s quarterback Cam Newton, the dance move is now seen in all sorts of sports celebrations, dance adaptations, videos and promotions. It is a fad, a craze — …
Read more
Impaired and On the Clock: Developing Policies and Procedures to Cope with Impairment in the Workplace
Brittany Tomkies Executive Editor Loyola University Chicago School of Law, JD 2017 Drug and substance abuse has become an epidemic in the United States over the past 15 years, reaching an alarming 9.4% of Americans ages 12 and older in 2013. The human and economic costs of substance abuse are astonishing – some estimate …
Read more
19 Ingredients, 2.2 Million Pounds of Product and $368.7 Million to Comply
Brittany Tomkies Executive Editor Loyola University Chicago School of Law, JD 2017 The Food and Drug Administration (FDA) issued a final rule on September 2, 2016 establishing that certain over-the-counter (OTC) consumer antiseptic wash products (i.e. antibacterial hand and body soaps) containing certain active ingredients can no longer be marketed as they are not generally …
Read more
Another Suit against Vanguard Healthcare
Kaitlin Lavin Executive Editor Loyola University Chicago School of Law, JD 2017 In 2011, Vanguard Healthcare, LLC (“Vanguard”) settled a whistleblower suit for Medicare and Medicaid fraud and entered into a Corporate Integrity Agreement (CIA). Now the federal government is suing Vanguard for submitting fraudulent claims for services that were “either non-existent or grossly …
Read more
FTC Final Order against LabMD – The Intersection of Unfair Practices, Privacy, Security, and Compliance
Logan Parker Privacy Editor Loyola University Chicago School of Law, LL.M. in Health Law 2017 The Federal Trade Commission (“FTC”) issued an Opinion and Final Order on July 29, 2016 against LabMD, a now defunct medical testing laboratory, for its lax data security practices that constituted an unfair practice under Section 5 of the …
Read more
Big Pharma Scorecard Encouraging Greater Clinical Trial Transparency
Kaitlin Lavin Executive Editor Loyola University Chicago School of Law, JD 2017 Bioethics International (BEI), a non-profit organization, is working to improve transparency and ethics in healthcare delivery and innovation by holding pharmaceutical companies accountable for compliance with the Food and Drug Administration Amendments Act (FDAAA). Many people do not trust drug companies, believing …
Read more